Pharmaceutical
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Strength
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Pack Size
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Form
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Source
European Medicines Agency
Safety Profile
Contraindications
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Side Effects
Kaftrio : Orphan maintenance assessment report (WS-2551) (post-authorisation)
Scan this QR code to access this page quickly on your mobile device.